Acadia Pharma (ACAD) Post Q3 Loss of $0.25/Share; Plans NUPLAZID NDA in Q1 2015
Go back to Acadia Pharma (ACAD) Post Q3 Loss of $0.25/Share; Plans NUPLAZID NDA in Q1 2015| Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) | Delayed: 28.78 +0.54 (1.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.24 | 52 Week High | $42.49 | |||
| Open | $28.63 | 52 Week Low | $16.64 | |||
| Day High | $28.79 | P/E | N/A | |||
| Day Low | $28.21 | EPS | $-0.42 | |||
| Volume | 492,311 | |||||
